Literature DB >> 4365979

Evidence that most noradrenaline is stored without ATP in sympathetic large dense core nerve vesicles.

H Lagercrantz, L Stajärne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4365979     DOI: 10.1038/249843a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  On the soluble phase of adrenergic nerve vesicles: correlation of matrix density and biochemical composition.

Authors:  H Lagercrantz; A Thureson-Klein
Journal:  Histochemistry       Date:  1975

2.  Subcellular localization of noradrenaline and ATP in C1300 mouse neuroblastoma.

Authors:  N H Fraeyman; W P De Potter; A F De Schaepdryver
Journal:  Experientia       Date:  1978-09-15

Review 3.  Purinergic signalling: ATP release.

Authors:  P Bodin; G Burnstock
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

4.  Antagonism by nifedipine of contraction and Ca2(+)-influx evoked by ATP in guinea-pig urinary bladder.

Authors:  T Katsuragi; S Usune; T Furukawa
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

5.  Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea-pig vas deferens.

Authors:  J L Ellis; G Burnstock
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

6.  Possible feed-back inhibition of noradrenaline release by purine compounds.

Authors:  M A Enero; B Q Saidman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

7.  Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?

Authors:  F Niklasson; H Agren; R Hällgren
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

Review 8.  Therapeutic potential of extracellular ATP and P2 receptors in nervous system diseases.

Authors:  Jie Tu; Li-Ping Wang
Journal:  Neurosci Bull       Date:  2009-02       Impact factor: 5.203

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.